Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

GeoVax discloses preliminary topline results from phase I trial of vaccine to control HIV infections

Jan. 15, 2014

FDA approves Isentress pediatric oral suspension

Jan. 10, 2014

FDA approves phase IIb study of PRO-140 for HIV-1

Jan. 9, 2014

Immune Response BioPharma announces development of a novel HIV/AIDS vaccine

Dec. 30, 2013

FDA approves Complera for patients with HIV switching from a stable regimen

Dec. 16, 2013

E.U. funding for iHIVARNA program of HIV therapeutic vaccine

Dec. 13, 2013

ImQuest BioSciences presents a novel anti-HIV microbicide gel

Dec. 11, 2013

ViiV Healthcare seeks approval for dolutegravir in Japan

Dec. 9, 2013

InnaVirVax initiates phase II study of VAC-3S with ART in HIV-1

Dec. 2, 2013

Janssen Pharma launches new formulation of darunavir in Japan

Nov. 29, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...